Date published: 2025-11-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR62 Inhibitors

GPR62, or G protein-coupled receptor 62, is part of a large family of cell surface receptors that play key roles in various physiological processes by transducing extracellular signals into cellular responses. These receptors are characterized by their seven-transmembrane domain architecture and are known to influence intracellular signaling cascades when activated by specific ligands. The expression of GPR62 is subject to precise regulatory control, as it is with many genes, which involves a complex interplay of transcriptional, post-transcriptional, and epigenetic mechanisms. The modulation of GPR62 expression can have significant effects on cellular function, though the full extent and biological context of these effects are areas of active investigation. Factors that can inhibit the expression of GPR62 may do so through direct or indirect interactions with these regulatory pathways, potentially leading to a decreased presence of the receptor on the cell surface and thus altering the cellular signaling landscape. A variety of chemical compounds have been identified that could potentially inhibit the expression of GPR62 by targeting the intricate machinery of gene regulation. Compounds like Trichostatin A and Vorinostat are known to inhibit histone deacetylases, enzymes that remove acetyl groups from histone proteins, leading to a more condensed chromatin state and reduced transcriptional activity of certain genes, including possibly GPR62. DNA methyltransferase inhibitors, such as 5-Azacytidine and Decitabine, can alter the methylation status of DNA at gene promoters, which may lead to the downregulation of gene expression. These compounds intercede at the epigenetic level, potentially reducing the transcription of genes like GPR62 by changing the accessibility of the DNA to the transcriptional machinery. Other inhibitors, like LY294002 and PD98059, act further downstream by targeting specific signaling pathways within the cell. LY294002, a PI3K inhibitor, and PD98059, a MEK inhibitor, may reduce GPR62 expression by altering the activity of transcription factors and signaling proteins that govern the transcription of the GPR62 gene. It is through these varied mechanisms that the expression of GPR62 could be subject to modulation by these chemicals, thereby providing insight into the regulation of this receptor's role in cellular communication.

Items 31 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING